A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

NCT06006169 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: BL-B01D1
DRUG: SI-B003

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.